Dr Paula Salmikangas, Director of Biopharmaceuticals and ATMPs at NDA, and Dr Tatiana Reimer, Principal Consultant at NDA, will be presenting different topics at International Society for Cell and Gene Therapy (ISCT) 2023.


Dr Paula Salmikangas will be presenting:

  • Wednesday, May 31 2023 at 08:00 - 09:00

Roundtable (GRP): Twice the Challenge? Gene Edited iPSC derived T-Cell and NK/NK-like Products for Cancer Therapy

  • Wednesday, May 31 2023 at 14:15 - 15:15 

Roundtable: How Emerging US and EU Regulations Impact your Product Development Strategy?

  • Friday, June 2 2023 at 17:00 - 18:00

Launch & Patient Access Concurrent: Regulatory revolution: global harmonization for safe personalized medicines


Dr Tatiana Reimer will be presenting:

  • Wednesday, May 31 2023 at 18.30 - 20.30

Poster Reception 1: Global regulatory landscape of cell and gene therapy products – how to ensure successful global submissions

Don't miss this opportunity!

See full program

The Presenters

Dr Paula Salmikangas

Advisory Board Director

Read More

 

Dr Tatiana Reimer

Principal Consultant

LinkedIn

Stay up to date

Contact us

Your drug development needs are unique

Contact us to learn how our experts can support you to meet all regulatory, quality and safety requirements and ensure the best path to approval.

Let's Bring Medicines to the World

  • This field is for validation purposes and should be left unchanged.